Related Experiment Video
Updated: Apr 14, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
Myotonic dystrophy-1 complicated by factor-v (leiden) mutation
Josef Finsterer1, Claudia Stöllberger2
1Krankenanstalt Rudolfstiftung, 1030 Vienna, Austria.
Abstract:
Objectives. Presence of a factor-V Leiden mutation in a patient with myotonic dystrophy type 1 (DM1) has been reported only once. Here we report the second DM1 patient carrying a factor-V mutation who died from long-term complications of this mutation. Case Report. A 66-year-old DM1 patient with multi-organ-disorder syndrome developed a first deep venous thrombosis (DVT) and consecutive pulmonary embolism (PE) at age 50 y. Acetyl-salicylic acid was given. One year later he experienced a second DVT; that is why phenprocoumon was started. Despite anticoagulation, he experienced a third DVT bilaterally and a second PE bilaterally at 61 y; that is why a vena cava filter was additionally deployed. Despite therapeutic anticoagulation, he experienced a vena cava filter thrombosis at age 62 y. Genetic workup revealed a heterozygous factor-V mutation in addition to a CTG-repeat expansion of 500. As a consequence of PE he developed chronic obstructive pulmonary disease and experienced recurrent pulmonary infections, which were lastly responsible for decease at age 66 y despite intensive care measures. Conclusion. The heterozygous Leiden mutation may severely affect DM1 patients to such a degree that they die from its complications. If DM1 patients present with unusual manifestations, search for causes other than a CTG-repeat expansion is indicated.
Insights
Myotonic dystrophy type 1 patients with factor V Leiden mutation face severe complications. This second reported case highlights the fatal risks of combined genetic mutations, emphasizing the need for broader genetic screening in DM1 patients with unusual symptoms.
Area of Science:
- Genetics
- Internal Medicine
- Pulmonology
Background:
- Myotonic dystrophy type 1 (DM1) is a multisystemic disorder.
- Factor V Leiden mutation is a common genetic risk factor for venous thromboembolism.
- The co-occurrence of DM1 and factor V Leiden mutation is exceedingly rare.
Purpose of the Study:
- To report the second case of a DM1 patient with a factor V Leiden mutation.
- To describe the long-term complications and fatal outcome in this patient.
- To highlight the potential severe impact of combined genetic mutations.
Main Methods:
- Case report of a 66-year-old male DM1 patient.
- Detailed clinical history including recurrent deep venous thrombosis (DVT) and pulmonary embolism (PE).
- Genetic analysis revealing heterozygous factor V mutation and CTG-repeat expansion (500).
Main Results:
- The patient experienced multiple DVTs, PEs, and vena cava filter thrombosis despite anticoagulation.
- Complications included chronic obstructive pulmonary disease and recurrent pulmonary infections.
- The patient died at age 66 due to complications secondary to PE.
Conclusions:
- The heterozygous factor V Leiden mutation can severely impact DM1 patients, potentially leading to fatal complications.
- Unusual manifestations in DM1 patients warrant investigation for co-existing genetic factors beyond the CTG-repeat expansion.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
ATP Synthase: Mechanism
Cardiomyopathy II: Dilated Cardiomyopathy
Satellite Stem Cells and Muscular Dystrophy
ATP Synthase: Structure
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...

